Heavily indebted poor countries (HIPC) vs Norway: Immunization, HepB3
Heavily indebted poor countries (HIPC)
73.9%
in 2024
Norway
96.0%
in 2024
Heavily indebted poor countries (HIPC) rank
44th
Norway rank
42nd
Immunization, HepB3 over time
- Heavily indebted poor countries (HIPC)
- Norway
How they compare
Norway currently reports 96.0% against 73.9% in Heavily indebted poor countries (HIPC), a difference of 22.1%.
That makes Norway's figure about 1.3 times Heavily indebted poor countries (HIPC)'s.
Across all 6 years both countries report, Norway has been ahead every year.
Heavily indebted poor countries (HIPC) ranks 44th and Norway ranks 42nd of 47 groups.
Norway has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Heavily indebted poor countries (HIPC) | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 77.5% | 96.0% | 18.5% | Norway |
| 2020s | 73.9% | 96.2% | 22.3% | Norway |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hepb3, Heavily indebted poor countries (HIPC) or Norway?
- Norway, at 96.0% against 73.9% in Heavily indebted poor countries (HIPC) as of 2024.
- What is the difference in immunization, hepb3 between Heavily indebted poor countries (HIPC) and Norway?
- 22.1%, with Norway ahead.
- How many years of comparable data are there for Heavily indebted poor countries (HIPC) and Norway?
- 6 years are reported by both, from 2019 to 2024.
- How do Heavily indebted poor countries (HIPC) and Norway rank globally for immunization, hepb3?
- Heavily indebted poor countries (HIPC) ranks 44th and Norway ranks 42nd of 47 groups.
- Where does this data come from?
- World Health Organization (WHO), published as Immunization, HepB3 (% of one-year-old children). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.